23 March 2023
“At 5% prevalence using summary data in symptomatic people during the first week after symptom onset, the positive predictive value (PPV) of 89% means that 1 in 10 positive results will be a false positive, and around 1 in 5 cases will be missed.
At 0.5% prevalence using summary data for asymptomatic people, where testing was widely available and where epidemiological exposure to COVID-19 was suspected, resulting PPVs would be 38% to 52%, meaning that between 2 in 5 and 1 in 2 positive results will be false positives, and between 1 in 2 and 1 in 3 cases will be missed.”19
References:
- False positive test result. National Cancer Institute. Accessed January 25, 2023. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/false-positive-test-result.
- Healy B, Khan A, Metezai H, et al. The impact of false positive COVID-19 results in an area of low prevalence. Clin Med (Lond). 2021;21(1):e54-e56. doi:10.7861/clinmed.2020-0839.
- Expert opinion. Interview with Laura-Leena Kiiskinen, Vice President Innovation and Business Development, Medix Biochemica. November 21, 2022.
- Petticrew M, Sowden A, Lister-Sharp D. False-negative results in screening programs. Medical, psychological, and other implications. Int J Technol Assess Health Care. 2001;17(2):164-170. doi:10.1017/s0266462300105021.
- Kufa T, Kharsany AB, Cawood C, et al. Misdiagnosis of HIV infection during a South African community-based survey: implications for rapid HIV testing. J Int AIDS Soc. 2017;20(Suppl 6):21753. doi:10.7448/IAS.20.7.21753.
- Malvagia S, Forni G, Ombrone D, et al. Development of strategies to decrease false positive results in newborn screening. Int J Neonatal Screen. 2020;6(4):84. doi:10.3390/ijns6040084.
- False-positive HIV test results. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Accessed January 25, 2023. https://www.cdc.gov/hiv/pdf/testing/cdc-hiv-factsheet-false-positive-test-results.pdf.
- Taksler GB, Keating NL, Rothberg MB. Implications of false-positives for future cancer screenings. Cancer. 2018;124(11):2390-2398. doi:10.1002/cncr.31271.
- Newborn screening overview. NHS.UK. Accessed January 25, 2023. https://www.nhs.uk/conditions/baby/newborn-screening/overview/.
- Newborn screening portal. Centers for Disease Control and Prevention. Accessed January 25, 2023. https://www.cdc.gov/newbornscreening/index.html.
- Tluczek A, Orland KM, Cavanagh L. Psychosocial consequences of false-positive newborn screens for cystic fibrosis. Qual Health Res. 2011;21(2):174-186. doi:10.1177/1049732310382919.
- Rosettenstein KR, Lain SJ, Wormleaton N, et al. A systematic review of the outcomes of false-positive results on newborn screening for congenital hypothyroidism. Clin Endocrinol (Oxf). 2021;95(5):766-781. doi:10.1111/cen.14562.
- Klarkowski D, O’Brien DP, Shanks L, et al. Causes of false-positive HIV rapid diagnostic test results. Expert Rev Anti Infect Ther. 2014;12(1):49-62. doi:10.1586/14787210.2014.866516.
- Johnson C, Fonner V, Sands A, et al. A report on the misdiagnosis of HIV status. Annex 14 to the Consolidated Guidelines on HIV Testing Services 2015. ISBN: 9789241508926.
- Coquillard N. Negligent HIV testing and false-positive plaintiffs: pardoning the traditional prerequisites for emotional distress recovery. Cleve St L Rev. 1995;43(4):655.
- Understanding a positive result. Centers for Disease Control and Prevention. Accessed January 31, 2023. https://www.cdc.gov/hiv/basics/hiv-testing/positive-hiv-results.html.
- HIV and AIDS epidemic global overview. HIV.Gov. Accessed January 31, 2023. https://www.hiv.gov/federal-response/pepfar-global-aids/global-hiv-aids-overview.
- Braunstein GD, Schwartz L, Hymel P, et al. False positive results with SARS-CoV-2 RT-PCR tests and how to evaluate a RT-PCR-positive test for the possibility of a false positive result. J Occup Environ Med. 2021;63(3):e159-e162. doi:10.1097/JOM.0000000000002138.
- Dinnes J, Sharma P, Berhane S, et al. Cochrane COVID-19 Diagnostic Test Accuracy Group. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection. Cochrane Database of Systematic Reviews 2022, Issue 7. doi: 10.1002/14651858.CD013705.pub3.
- Expert opinion. Interview with Kevin Eboigbodin, PhD, MBA, Adj. Prof. Senior Director, Molecular Diagnostic Reagents at Medix Biochemica, Adj. Professor in Molecular Biology at University of Helsinki. November 17, 2022.
- Olliaro P, Torreele E. Managing the risks of making the wrong diagnosis: first, do no harm. Int J Infect Dis. 2021;106:382-385. doi:10.1016/j.ijid.2021.04.004.
- What we IVDo. Medix Biochemica. Accessed January 31, 2023. https://www.medixbiochemica.com/what-we-ivdo.
- Antibodies/antigens/enzymes. Medix Biochemica. Accessed January 31, 2023. https://www.medixbiochemica.com/antibodies-antigens-enzymes.
- FAQs. Medix Biochemica. Accessed February 2, 2023. https://www.medixbiochemica.com/faqs.
- Kanto L, Svens E, Tiisala S. Comparison of eight commercial PROM tests: Actim® PROM is the only test not reporting PROM false positives for maternal sera, and not exhibiting hook effect. Medix Biochemica, Klovinpellontie 3, FI-02180 Espoo, Finland. November 2018.